SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancer.
Mauro J, Mueller M, Perrone E, Bruno V, Restaino S, De Ponti E, Imboden S, Garcia-Pineda V, Taskin S, Grassi T, Siegenthaler F, Casarin J, Raimondo D, Capozzi VA, Vatansever D, Capasso I, Vizza E, Gungor M, Zapardiel I, Papadia A, Fruscio R, Taskiran C, Vizzielli G, Fanfani F, Scambia G, Buda A.
Mauro J, et al. Among authors: de ponti e.
Eur J Surg Oncol. 2025 Jul;51(7):109750. doi: 10.1016/j.ejso.2025.109750. Epub 2025 Mar 6.
Eur J Surg Oncol. 2025.
PMID: 40163975